StockNews.com Begins Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS)
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Shares of ADXS opened at $0.88 on Tuesday. The firm has a market cap of $1.60 million, a P/E ratio of […]